Semantix (STIX) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock STIX vs. CDLX, DUOT, GAN, ZENA, LGCL, BNZI, ZENV, CNGL, GMM, and ZSPCShould you be buying Semantix stock or one of its competitors? The main competitors of Semantix include Cardlytics (CDLX), Duos Technologies Group (DUOT), GAN (GAN), ZenaTech (ZENA), Lucas GC (LGCL), Banzai International (BNZI), Zenvia (ZENV), Canna-Global Acquisition (CNGL), Global Mofy AI (GMM), and zSpace (ZSPC). These companies are all part of the "computer software" industry. Semantix vs. Its Competitors Cardlytics Duos Technologies Group GAN ZenaTech Lucas GC Banzai International Zenvia Canna-Global Acquisition Global Mofy AI zSpace Semantix (NASDAQ:STIX) and Cardlytics (NASDAQ:CDLX) are both small-cap computer software companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, earnings, dividends, institutional ownership, profitability, analyst recommendations, risk and media sentiment. Which has higher valuation and earnings, STIX or CDLX? Semantix has higher earnings, but lower revenue than Cardlytics. Cardlytics is trading at a lower price-to-earnings ratio than Semantix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSemantix$264.23M0.00-$63.61M-$0.81N/ACardlytics$272.59M0.35-$189.30M-$3.56-0.50 Does the media prefer STIX or CDLX? In the previous week, Cardlytics had 3 more articles in the media than Semantix. MarketBeat recorded 3 mentions for Cardlytics and 0 mentions for Semantix. Cardlytics' average media sentiment score of 0.93 beat Semantix's score of 0.00 indicating that Cardlytics is being referred to more favorably in the news media. Company Overall Sentiment Semantix Neutral Cardlytics Positive Is STIX or CDLX more profitable? Cardlytics has a net margin of -65.41% compared to Semantix's net margin of -69.49%. Semantix's return on equity of -45.45% beat Cardlytics' return on equity.Company Net Margins Return on Equity Return on Assets Semantix-69.49% -45.45% -26.98% Cardlytics -65.41%-172.36%-42.07% Do analysts prefer STIX or CDLX? Cardlytics has a consensus price target of $3.50, indicating a potential upside of 94.99%. Given Cardlytics' stronger consensus rating and higher probable upside, analysts plainly believe Cardlytics is more favorable than Semantix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Semantix 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Cardlytics 1 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.14 Do institutionals & insiders believe in STIX or CDLX? 40.1% of Semantix shares are owned by institutional investors. Comparatively, 68.1% of Cardlytics shares are owned by institutional investors. 35.5% of Semantix shares are owned by insiders. Comparatively, 4.4% of Cardlytics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more volatility & risk, STIX or CDLX? Semantix has a beta of -0.37, indicating that its stock price is 137% less volatile than the S&P 500. Comparatively, Cardlytics has a beta of 1.21, indicating that its stock price is 21% more volatile than the S&P 500. SummaryCardlytics beats Semantix on 9 of the 15 factors compared between the two stocks. Get Semantix News Delivered to You Automatically Sign up to receive the latest news and ratings for STIX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding STIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STIX vs. The Competition Export to ExcelMetricSemantixCustom computer programming services IndustryComputer SectorNASDAQ ExchangeMarket Cap$23.73M$1.68B$28.12B$9.29BDividend YieldN/AN/A3.14%4.03%P/E Ratio0.007.7632.9719.63Price / SalesN/A4.261,720.9596.94Price / CashN/A34.9937.6457.93Price / BookN/A3.657.565.61Net Income-$63.61M$15.21M$779.73M$257.74M Semantix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STIXSemantixN/AN/AN/AN/A$23.73M$264.23M0.004CDLXCardlytics3.6051 of 5 stars$1.78-0.6%$3.50+96.6%-79.7%$93.45M$272.59M-0.50500News CoverageDUOTDuos Technologies Group2.7223 of 5 stars$7.92+2.2%$12.50+57.8%+138.9%$92.27M$7.28M-6.6070GANGANN/A$1.97flatN/AN/A$91.53M$133.71M-6.57680ZENAZenaTechN/A$3.89+3.2%$9.00+131.4%N/A$87.53M$1.96M0.0011Gap UpLGCLLucas GCN/A$1.06flatN/A-57.8%$84.24M$145.69M0.00361Positive NewsBNZIBanzai International4.455 of 5 stars$4.42-4.7%$240.00+5,329.9%-95.4%$83.80M$4.53M0.0012Gap DownHigh Trading VolumeZENVZenvia2.7035 of 5 stars$1.47+0.3%N/A-8.1%$76.09M$177.97M-4.581,080Positive NewsCNGLCanna-Global AcquisitionN/A$10.74flatN/AN/A$70.99MN/A0.002GMMGlobal Mofy AI1.2438 of 5 stars$2.75+1.1%N/A-78.6%$69.11M$41.36M0.0038Positive NewsGap UpZSPCzSpaceN/A$3.00-2.9%$15.00+400.0%N/A$68.64M$38.10M0.0070Gap UpHigh Trading Volume Related Companies and Tools Related Companies Cardlytics Competitors Duos Technologies Group Competitors GAN Competitors ZenaTech Competitors Lucas GC Competitors Banzai International Competitors Zenvia Competitors Canna-Global Acquisition Competitors Global Mofy AI Competitors zSpace Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:STIX) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredMajor Rollout of Social Security X?To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Next Commodity Crisis Just Got a Name: SilverElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Semantix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Semantix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.